🔗 Share this article Social Media Influencers Driving Unofficial Trade for Unapproved Weight-Loss Drug A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings. Investigational Drug Gaining Traction Via Social Media Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining discount codes. Thriving Commerce on Messaging Platforms Additionally, a flourishing trade exists on Telegram, where communities with thousands of participants share comparison photos, injection guides and assertions of rapid UK delivery. Vendors market the substance there before directing buyers to WhatsApp for transactions. Learning About Retatrutide Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic. Healthcare Professionals Express Concerns However, physicians and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals injecting products of uncertain source. Several experts said the popularity for retatrutide could be connected to the increasing price of licensed weight loss products such as Mounjaro. Regulatory Position and Enforcement Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012. Several content creators try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still violate medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or prison. Platform Reaction and Material Elimination According to the social media company, the service has taken down problematic content and prohibited related hashtags and search suggestions. The company said it was dedicated to maintaining the service safe and allocating resources in strengthening enforcement strategies. Online Trading Operations Investigations also discovered groups with up to nine thousand members selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of weight loss, positive testimonials and step-by-step guides for mixing or injecting at home. Within minutes of entering one community, a seller shared WhatsApp details, where most purchases occur. The seller sent an guidebook and guaranteed shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about weight, health issues or previous experience. Product Information and Costs Within these groups, messages display black plastic packages with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.” Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”. Service Oversight and Security Actions A representative for the messaging service said it actively moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”. Medical Expert Cautions “People are injecting substances they can’t verify. Even if the research behind this drug is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service. Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said. Her team has previously seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.” Manufacturer Position A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to possibly serious medical dangers”.